Skip to main content

ADDAVEN concentrated injection ampoule, Fresenius Kabi Australia Pty Ltd, CON-499

Product name
ADDAVEN concentrated injection ampoule
Sponsor name
Fresenius Kabi Australia Pty Ltd
Consent start
Consent no.
CON-499
Standard
Paragraph 10(4)(d) of the Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product ampoule label lists the active ingredients aselemental symbols with oxidation state, instead of their full names sodium molybdatedehydrate (shown on ampoule label as Mo6+), manganese chloride tetrahydrate (ampoule label Mn2+), sodium fluoride (ampoule label F-), chromic chloride hexahydrate(ampoulelabel Cr3+), ferric chloride hexahydrate (ampoule label Fe3+), zinc chloride (ampoule label Zn2+), sodium selenite (ampoule label Se4+), potassium iodide (ampoule label I-) andcupric chloride dehydrate (ampoule label Cu2+). Additionally, the text size for the active ingredient elemental symbols is less than 2.0 mm (approximately 1.3 mm).
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site